NBIX Neurocrine Biosciences Inc

Neurocrine Biosciences Inc engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.

$86.54  +0.36 (0.42%)
As of 05/23/2022 15:59:59 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/26/2001
Outstanding shares:  95,576,662
Average volume:  860,417
Market cap:   $8,159,379,635
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2623911
Valuation   (See tab for details)
PE ratio:   115.36
PB ratio:   5.92
PS ratio:   6.76
Return on equity:   5.13%
Net income %:   5.91%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy